News | December 19, 2011

Cardiovascular Societies Call for More Stringent Review Policies to Avoid Overuse of Stents


December 19, 2011 – The Maryland Chapter of the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI) reiterated their call for the state of Maryland to require rigorous internal and external review of stenting practices in hospitals in the state after an advisory group recommended a lower standard.

“Our priority is to ensure patients will receive safe, appropriate, high-quality cardiovascular care,” said Samuel D. Goldberg, M.D., FACC, president of the Maryland Chapter of the ACC. “By requiring each hospital to submit a written plan on an annual basis detailing how it will conduct regular internal and external review of its stenting practices, the state will be enacting important protections for Maryland’s patients.”

The Maryland Health Care Commission’s Technical Advisory Group recommended giving the Commission authority to regulate stent services as well as continuing evaluation of hospitals with stent programs, but the group stopped short of requiring an internal review that meets specific standards and an external peer review as an auditing mechanism.

Two high-profile stenting cases in Maryland hospitals were the result of “inadequate, voluntary, internal review,” Goldberg and SCAI President Christopher J. White, M.D., FSCAI, said in a letter to the Maryland Health Care Commission, which is considering the advisory group’s recommendation. The medical societies are recommending a two-pronged system of checks, including a well-defined internal review process combined with regular audits through external peer review.

The MDACC and SCAI letter to the commission can be found here: http://mhcc.maryland.gov/pci/comments_received/mdacc_pci.pdf

 


Related Content

News | Stents

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
News | Stents

March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...

Home March 08, 2024
Home
News | Stents

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
News | Stents

November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home November 29, 2023
Home
News | Stents

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
News | Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
News | Stents

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
News | Stents

January 23, 2023 — A study of more than 100,000 patients has revealed that, for patients with blockages in multiple ...

Home January 23, 2023
Home
News | Stents

July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (<2,5mm) evaluated the efficacy and ...

Home July 05, 2022
Home
News | Stents

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the ...

Home June 02, 2022
Home
Subscribe Now